Doctor profile · Federal record
Dr. Wilfredo Rivera, MD
Cardiovascular Disease Physician (CMS: Cardiovascular Disease (Cardiology)) · Flint, MI
- NPI 1023170388
- Accepts Medicare
- 39 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
2335 S Linden RD
Flint, MI 485325497
(810) 720-2400
fax (810) 720-2401
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- March 3, 2011
- Year of graduation
- 1987 — 39 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Michigan #4301063815
- Medicaid
- MI #103420840
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1023170388. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,640
Distinct HCPCS
10
Medicare allowed
$451,154
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2785 |
Injection, regadenoson, 0.1 mg | 764 | 190 | $54 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 503 | 202 | $77 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 485 | 335 | $122 | |
A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose | 411 | 205 | $152 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 398 | 362 | $14 | |
J0280 |
Injection, aminophyllin, up to 250 mg | 233 | 77 | $9 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 232 | 228 | $185 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 206 | 204 | $59 | |
78452 |
Nuclear medicine studies of heart muscle at rest and with stress and spect | 205 | 204 | $407 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 180 | 165 | $128 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 126. This provider delivers 37× the peer median.Open Payments
Industry payments received
All-time total
$287
Transactions
11
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Medtronic, Inc. | 2 | $128.02 | |
| Kestra Medical Technology Services, Inc. | 3 | $46.60 | |
| PFIZER INC. | 2 | $36.91 | |
| SCPHARMACEUTICALS INC. | 1 | $21.12 | |
| Lexicon Pharmaceuticals, Inc. | 1 | $19.80 | |
| MERZ NORTH AMERICA, INC. | 1 | $19.51 | |
| Amgen Inc. | 1 | $15.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,398
Patients
1,416
Total drug cost
$1,283,343
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 505 | 149 | $662,889 |
| Atorvastatin Calcium | Generic | 498 | 159 | $11,578 |
| Metoprolol Succinate | Generic | 435 | 134 | $11,545 |
| Rosuvastatin Calcium | Generic | 415 | 145 | $15,358 |
| Furosemide | Generic | 294 | 112 | $2,324 |
| Metoprolol Tartrate | Generic | 286 | 97 | $3,455 |
| Carvedilol | Generic | 272 | 84 | $3,573 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 247 | 83 | $5,042 |
| Losartan Potassium | Generic | 245 | 81 | $5,997 |
| Entresto (Sacubitril/Valsartan) | Brand | 231 | 61 | $327,853 |
Hospital affiliations
Frequently asked questions
What is Dr. Wilfredo Rivera's medical specialty?
Dr. Wilfredo Rivera practices Cardiovascular Disease Physician in Flint, MI.
Where does Dr. Wilfredo Rivera practice?
Dr. Wilfredo Rivera practices at 2335 S Linden RD, Flint, MI 485325497. Office phone: 8107202400.
What is Dr. Wilfredo Rivera's NPI?
Dr. Wilfredo Rivera's National Provider Identifier (NPI) is 1023170388, issued by NPPES.
Does Dr. Wilfredo Rivera accept Medicare assignment?
Yes. Dr. Wilfredo Rivera accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Wilfredo Rivera commonly perform?
Top Medicare-reported procedures in 2023: Injection, regadenoson, 0.1 mg (HCPCS J2785); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.